A systematic review of neurological symptoms and complications of COVID-19

[1]  D. Wichmann.  Autopsy Findings and Venous Thromboembolism in Patients With COVID-19 , 2020, Annals of Internal Medicine.

[2]  S. Farhadian,et al.  Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. , 2020, JAMA neurology.

[3]  C. Lucchinetti,et al.  Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology , 2020, Acta Neuropathologica.

[4]  R. Sebra,et al.  Pathophysiology of SARS-CoV-2: targeting of endothelial cells renders a complex disease with thrombotic microangiopathy and aberrant immune response. The Mount Sinai COVID-19 autopsy experience , 2020, medRxiv.

[5]  K. Blennow,et al.  Steroid‐Responsive Encephalitis in Coronavirus Disease 2019 , 2020, Annals of neurology.

[6]  Victor G. Puelles,et al.  Multiorgan and Renal Tropism of SARS-CoV-2 , 2020, The New England journal of medicine.

[7]  David S. Fischer,et al.  Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target cells , 2020, bioRxiv.

[8]  Josemir W Sander,et al.  New onset acute symptomatic seizure and risk factors in coronavirus disease 2019: A retrospective multicenter study , 2020, Epilepsia.

[9]  Shuilin Jin,et al.  The scRNA-seq expression profiling of the receptor ACE2 and the cellular protease TMPRSS2 reveals human organs susceptible to COVID-19 infection , 2020, bioRxiv.

[10]  J. Benito-León,et al.  Miller Fisher syndrome and polyneuritis cranialis in COVID-19 , 2020, Neurology.

[11]  K. Blennow,et al.  Steroid-responsive severe encephalopathy in SARS-CoV-2 infection , 2020, medRxiv.

[12]  Lisa Duong,et al.  Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in Downtown Los Angeles, early April 2020 , 2020, Brain, Behavior, and Immunity.

[13]  Y. Dai,et al.  [Clinical analysis of 150 cases of 2019 novel coronavirus infection in Nanyang City, Henan Province]. , 2020, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.

[14]  S. Kremer,et al.  Neurologic Features in Severe SARS-CoV-2 Infection , 2020, The New England journal of medicine.

[15]  Ruth Levinson,et al.  Anosmia and dysgeusia in patients with mild SARS-CoV-2 infection , 2020, medRxiv.

[16]  Carol H. Yan,et al.  Association of chemosensory dysfunction and COVID‐19 in patients presenting with influenza‐like symptoms , 2020, International forum of allergy & rhinology.

[17]  T. Lv,et al.  Encephalitis as a clinical manifestation of COVID-19 , 2020, Brain, Behavior, and Immunity.

[18]  L. Mao,et al.  Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. , 2020, JAMA neurology.

[19]  Mario Plebani,et al.  Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis , 2020, Clinical chemistry and laboratory medicine.

[20]  L. French,et al.  The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains , 2020, bioRxiv.

[21]  R. Carlier,et al.  Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study , 2020, European Archives of Oto-Rhino-Laryngology.

[22]  N. Enomoto,et al.  A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 , 2020, International Journal of Infectious Diseases.

[23]  Dingding Shen,et al.  Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? , 2020, The Lancet Neurology.

[24]  Akhtar Hussain,et al.  COVID-19 and diabetes: Knowledge in progress , 2020, Diabetes Research and Clinical Practice.

[25]  N. Kabbani,et al.  Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk , 2020, Molecular Pharmacology.

[26]  Suresh Patel,et al.  COVID-19–associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features , 2020, Radiology.

[27]  Z. Zeng,et al.  [Diagnosis and treatment of an elderly patient with secondary cerebral infarction caused by COVID-19]. , 2020, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[28]  S. Matalon,et al.  Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility , 2020, Physiological reviews.

[29]  Ke Ma,et al.  Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study , 2020, BMJ.

[30]  Sunny H Wong,et al.  Covid‐19 and the digestive system , 2020, Journal of gastroenterology and hepatology.

[31]  Shuke Nie,et al.  Acute myelitis after SARS-CoV-2 infection: a case report. , 2020, medRxiv.

[32]  Usman Ali,et al.  Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms , 2020, ACS chemical neuroscience.

[33]  Bo Li,et al.  Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China , 2020, Clinical Research in Cardiology.

[34]  F. Zhou,et al.  A case of coronavirus disease 2019 with tuberculous meningitis , 2020 .

[35]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[36]  Y. Xian,et al.  Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study , 2020, Stroke and vascular neurology.

[37]  Hengcheng Zhu,et al.  Clinical characteristics of 82 death cases with COVID-19 , 2020, medRxiv.

[38]  Tsutomu Hashikawa,et al.  The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients , 2020, Journal of medical virology.

[39]  Wei Wang,et al.  Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis , 2020, European Respiratory Journal.

[40]  Zhenli Guo,et al.  The 2019 novel cornoavirus pneumonia with onset of oculomotor nerve palsy: a case study , 2020, Journal of Neurology.

[41]  Heshui Shi,et al.  Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet Infectious Diseases.

[42]  Zhigang Tian,et al.  Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus , 2020, bioRxiv.

[43]  Dengju Li,et al.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.

[44]  B. Graham,et al.  Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.

[45]  Ralph S. Baric,et al.  Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus , 2020, Journal of Virology.

[46]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[47]  Alain Le Coupanec,et al.  Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? , 2019, Viruses.

[48]  E. Ely,et al.  Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms , 2019, Critical Care.

[49]  Nick C Fox,et al.  Associations Between Vascular Risk Across Adulthood and Brain Pathology in Late Life , 2019, JAMA neurology.

[50]  M. Diamond,et al.  Mechanisms of Pathogen Invasion into the Central Nervous System , 2019, Neuron.

[51]  Alexis M. Kalergis,et al.  Neurologic Alterations Due to Respiratory Virus Infections , 2018, Front. Cell. Neurosci..

[52]  J. Gorodkin,et al.  TISSUES 2.0: an integrative web resource on mammalian tissue expression , 2018, Database : the journal of biological databases and curation.

[53]  J. Gorodkin,et al.  TISSUES 2.0: an integrative web resource on mammalian tissue expression , 2018, Database J. Biol. Databases Curation.

[54]  A. Baig.  Emerging Insights for Better Delivery of Chemicals and Stem Cells to the Brain. , 2017, ACS chemical neuroscience.

[55]  A. Dejean,et al.  Foxo3 Transcription Factor Drives Pathogenic T Helper 1 Differentiation by Inducing the Expression of Eomes. , 2016, Immunity.

[56]  T. Kuiken,et al.  The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system , 2015, The Journal of pathology.

[57]  David K. Meyerholz,et al.  Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2 , 2008, Journal of Virology.

[58]  Motohiko Suzuki,et al.  Identification of Viruses in Patients With Postviral Olfactory Dysfunction , 2007, The Laryngoscope.

[59]  Bo Zhang,et al.  Multiple organ infection and the pathogenesis of SARS , 2005, The Journal of experimental medicine.

[60]  Jingyu Su,et al.  SARS-COV-2 Infection Causes Dyslipidemia and Increases Levels of Cancer Biomarkers in COVID-19 Patients , 2020 .